Black Diamond Therapeutics(BDTX) - 2023 Q3 - Quarterly Report

SECURITIES AND EXCHANGE COMMISSION | --- | --- | --- | |---------------------------------------------------------------------------------------|---------------------------------------|-------------------------------------------------------| | Securities registered pursuant to Section 12(b) \nTitle of each class | of the Act: \nTrading Symbol(s) | Name of each exchange on which registered | | Common stock, par value $0.0001 | BDTX | The Nasdaq Global Select Market | Non-accelerated filer ☒ Smaller reporting ...